In addition, treatment with an Shh pathway inhibitor partially reversed the effect of EDT, but did not completely eliminate the effect, indicating that the targets of EDT may be diverse and that Shh signalling may be one of the pathways through which EDT protects against colitis. Here, SHH is linked to colitis.